Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- RPE:
-
Retinal pigment epithelium
- AMD:
-
Age-related macular degeneration
- iPSC:
-
Induced pluripotent stem cell
- iPSC-RPE:
-
Induced pluripotent stem cell-derived RPE
- hESC:
-
Human embryonic stem cell
- hESC-RPE:
-
Human embryonic stem cell-derived RPE
- HLA:
-
Human leukocyte antigen
- OSKM:
-
Oct4, Sox2, Klf4, and c-Myc
- OSNL:
-
Oct4, Sox2, Nanog, and Lin28
- ACT:
-
Advanced Cell Technology, Inc
References
Strauss O (2005) The retinal pigment epithelium in visual function. Physiol Rev 85(3):845–881
Congdon N, O’Colmain B, Klaver CC, Klein R, Munoz B, Friedman DS et al (2004) Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol 122(4):477–485
Resnikoff S, Pascolini D, Etya’ale D, Kocur I, Pararajasegaram R, Pokharel GP et al (2004) Global data on visual impairment in the year 2002. Bull World Health Organ 82(11):844–851
Friedman DS, O’Colmain BJ, Munoz B, Tomany SC, McCarty C, de Jong PT et al (2004) Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 122(4):564–572
Bird AC (2010) Therapeutic targets in age-related macular disease. J Clin Invest 120(9):3033–3041
Algvere PV, Gouras P, Dafgard Kopp E (1999) Long-term outcome of RPE allografts in non-immunosuppressed patients with AMD. Eur J Ophthalmol 9(3):217–230
Cahill MT, Freedman SF, Toth CA (2003) Macular translocation with 360 degrees peripheral retinectomy for geographic atrophy. Arch Ophthalmol 121(1):132–133
Joussen AM, Joeres S, Fawzy N, Heussen FM, Llacer H, van Meurs JC et al (2007) Autologous translocation of the choroid and retinal pigment epithelium in patients with geographic atrophy. Ophthalmology 114(3):551–560
Zhang X, Bok D (1998) Transplantation of retinal pigment epithelial cells and immune response in the subretinal space. Invest Ophthalmol Vis Sci 39(6):1021–1027
Marc R (2005) Retinal remodeling. J Vis 5(12):5
Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K et al (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131(5):861–872
Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S et al (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318(5858):1917–1920
Aoi T, Yae K, Nakagawa M, Ichisaka T, Okita K, Takahashi K et al (2008) Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science 321(5889):699–702
Bock C, Kiskinis E, Verstappen G, Gu H, Boulting G, Smith ZD et al (2011) Reference maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines. Cell 144(3):439–452
Hussein SM, Batada NN, Vuoristo S, Ching RW, Autio R, Narva E et al (2011) Copy number variation and selection during reprogramming to pluripotency. Nature 471(7336):58–62
Laurent LC, Ulitsky I, Slavin I, Tran H, Schork A, Morey R et al (2011) Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture. Cell Stem Cell 8(1):106–118
Markoulaki S, Hanna J, Beard C, Carey BW, Cheng AW, Lengner CJ et al (2009) Transgenic mice with defined combinations of drug-inducible reprogramming factors. Nat Biotechnol 27(2):169–171
Mayshar Y, Ben-David U, Lavon N, Biancotti JC, Yakir B, Clark AT et al (2010) Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Cell Stem Cell 7(4):521–531
Quinlan AR, Boland MJ, Leibowitz ML, Shumilina S, Pehrson SM, Baldwin KK et al (2011) Genome sequencing of mouse induced pluripotent stem cells reveals retroelement stability and infrequent DNA rearrangement during reprogramming. Cell Stem Cell 9(4):366–373
Zhao T, Zhang Z-N, Rong Z, Xu Y (2011) Immunogenicity of induced pluripotent stem cells. Nature 474(7350):212–215
Idelson M, Alper R, Obolensky A, Ben-Shushan E, Hemo I, Yachimovich-Cohen N et al (2009) Directed differentiation of human embryonic stem cells into functional retinal pigment epithelium cells. Cell Stem Cell 5(4):396–408
Klimanskaya I, Hipp J, Rezai KA, West M, Atala A, Lanza R (2004) Derivation and comparative assessment of retinal pigment epithelium from human embryonic stem cells using transcriptomics. Cloning Stem Cells 6(3):217–245
Lund RD, Wang S, Klimanskaya I, Holmes T, Ramos-Kelsey R, Lu B et al (2006) Human embryonic stem cell-derived cells rescue visual function in dystrophic RCS rats. Cloning Stem Cells 8(3):189–199
Meyer JS, Shearer RL, Capowski EE, Wright LS, Wallace KA, McMillan EL et al (2009) Modeling early retinal development with human embryonic and induced pluripotent stem cells. Proc Natl Acad Sci 106(39):16698–16703
Vugler A, Carr AJ, Lawrence J, Chen LL, Burrell K, Wright A et al (2008) Elucidating the phenomenon of HESC-derived RPE: anatomy of cell genesis, expansion and retinal transplantation. Exp Neurol 214(2):347–361
Buchholz DE, Hikita ST, Rowland TJ, Friedrich AM, Hinman CR, Johnson LV et al (2009) Derivation of functional retinal pigmented epithelium from induced pluripotent stem cells. Stem Cells 27(10):2427–2434
Carr AJ, Vugler AA, Hikita ST, Lawrence JM, Gias C, Chen LL et al (2009) Protective effects of human iPS-derived retinal pigment epithelium cell transplantation in the retinal dystrophic rat. PLoS One 4(12):e8152
Hirami Y, Osakada F, Takahashi K, Okita K, Yamanaka S, Ikeda H et al (2009) Generation of retinal cells from mouse and human induced pluripotent stem cells. Neurosci Lett 458(3):126–131
Krohne T, Westenskow P, Kurihara T, Friedlander D, Lehmann M, Dorsey A et al (2012) Generation of retinal pigment epithelial cells from small molecules and OCT4-reprogrammed human induced pluripotent stem cells. Stem Cells Trans Med 1(2):96–109
Osakada F, Jin ZB, Hirami Y, Ikeda H, Danjyo T, Watanabe K et al (2009) In vitro differentiation of retinal cells from human pluripotent stem cells by small-molecule induction. J Cell Sci 122(Pt 17):3169–3179
Mircheff AK, Miller SS, Farber DB, Bradley ME, O’Day WT, Bok D (1990) Isolation and provisional identification of plasma membrane populations from cultured human retinal pigment epithelium. Invest Ophthalmol Vis Sci 31(5):863–878
Kokkinaki M, Sahibzada N Golestaneh N (2011) Human induced pluripotent stem-derived retinal pigment epithelium (RPE) cells exhibit ion transport, membrane potential, polarized vascular endothelial growth factor secretion, and gene expression pattern similar to native RPE. Stem Cells 29(5):825–835
Carr AJ, Vugler A, Lawrence J, Chen LL, Ahmado A, Chen FK et al (2009) Molecular characterization and functional analysis of phagocytosis by human embryonic stem cell-derived RPE cells using a novel human retinal assay. Mol Vis 15:283–295
Westenskow PD, Moreno SK, Krohne TU, Kurihara T, Zhu S, Zhang ZN et al (2012) Using flow cytometry to compare the dynamics of photoreceptor outer segment phagocytosis in iPS-derived RPE cells. Invest Ophthalmol Vis Sci 53(10):6282–6290
Schwartz SD, Hubschman J-P, Heilwell G, Franco-Cardenas V, Pan CK, Ostrick RM et al (2012) Embryonic stem cell trials for macular degeneration: a preliminary report. Lancet 379(9817):713–720
Lu B, Malcuit C, Wang S, Girman S, Francis P, Lemieux L et al (2009) Long-term safety and function of RPE from human embryonic stem cells in preclinical models of macular degeneration. Stem Cells 27(9):2126–2135
Sheridan C, Williams R, Grierson I (2004) Basement membranes and artificial substrates in cell transplantation. Graefes Arch Clin Exp Ophthalmol 242(1):68–75
Williams RL, Krishna Y, Dixon S, Haridas A, Grierson I, Sheridan C (2005) Polyurethanes as potential substrates for sub-retinal retinal pigment epithelial cell transplantation. J Mater Sci Mater Med 16(12):1087–1092
Okita K, Ichisaka T, Yamanaka S. 2007 Generation of germline-competent induced pluripotent stem cells. Nature 448(7151):313–317
Karamehic J, Ridic O, Jukic T, Ridic G, Slipicevic O, Coric J et al (2011) Financial aspects of the immunosuppressive therapy. Med Arh 65(6):357–362
Tezel TH, Del Priore LV, Berger AS, Kaplan HJ (2007) Adult retinal pigment epithelial transplantation in exudative age-related macular degeneration. Am J Ophthalmol 143(4):584–595
Eiraku M, Takata N, Ishibashi H, Kawada M, Sakakura E, Okuda S et al (2011) Self-organizing optic-cup morphogenesis in three-dimensional culture. Nature 472(7341):51–56
Nakano T, Ando S, Takata N, Kawada M, Muguruma K, Sekiguchi K et al (2012) Self-formation of optic cups and storable stratified neural retina from human ESCs. Cell Stem Cell 10(6):771–785
Acknowledgments
We wish to warmly thank all members of the Friedlander lab and our collaborators. Work discussed in this chapter was supported by generous funding to PDW, a Ruth Kirschstein Fellow (NEI EY021416), to TK (Manpei Suzuki Diabetes Foundation and The Japan Society for the Promotion of Science Postdoctoral Fellowships for Research Abroad), and to MF from the NEI (EY11254; EY017540), the California Institute for Regenerative Medicine (CIRM TR1–01219), the Lowy Medical Research Foundation (the MacTel Project), and the Rasmussen Foundation.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media, LLC
About this paper
Cite this paper
Westenskow, P., Kurihara, T., Friedlander, M. (2014). Utilizing Stem Cell-Derived RPE Cells as A Therapeutic Intervention for Age-Related Macular Degeneration. In: Ash, J., Grimm, C., Hollyfield, J., Anderson, R., LaVail, M., Bowes Rickman, C. (eds) Retinal Degenerative Diseases. Advances in Experimental Medicine and Biology, vol 801. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-3209-8_41
Download citation
DOI: https://doi.org/10.1007/978-1-4614-3209-8_41
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-3208-1
Online ISBN: 978-1-4614-3209-8
eBook Packages: MedicineMedicine (R0)